Funds holding it
1
Company page
GRIFOLS SA
US3984384087 · G0FB.F (FRA)
Avg. weight
0.06%
Price
6.75 EUR
Sector
Healthcare
Industry
Drug Manufacturers - General
Price for G0FB.F (FRA), updated 2026-08-16. Source: Yahoo Finance.
1-year price history
Source: Yahoo FinanceThe chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.
Funds holding this company
| Fund | Manager | Weight | Period |
|---|---|---|---|
| Azvalor | AZVALOR ASSET MANAGEMENT, SGIIC, S.A. | 0.06% | H1 2026 |
About the company
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others.
Source: Yahoo Finance.
Objective ratios
12.5%
5.36x
—
5.95 – 9.30 EUR
Data as-is, not an interpretation: it does not say whether the price is cheap or expensive, and it is not a buy or sell recommendation.
Updated 2026-08-14. Source: Yahoo Finance.
This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.